Valuation Metrics: A Closer Look
Kanoria Chemicals currently trades at a price of ₹93.60, down 1.24% from the previous close of ₹94.78. The stock’s 52-week range spans from ₹55.72 to ₹104.15, indicating significant volatility over the past year. The company’s price-to-earnings (P/E) ratio stands at an elevated 263.98, a figure that is substantially higher than typical industry standards and peer averages. This high P/E ratio suggests that the market is pricing in expectations of future growth or that current earnings are depressed, warranting cautious interpretation.
In contrast, the price-to-book value (P/BV) ratio is a modest 0.78, which is below the standard benchmark of 1.0, signalling that the stock is trading below its book value and may be undervalued on a net asset basis. This juxtaposition of a very high P/E with a low P/BV ratio highlights a complex valuation scenario where earnings are currently low or volatile, but the underlying asset base retains value.
Other valuation multiples include an enterprise value to EBITDA (EV/EBITDA) ratio of 11.32 and an enterprise value to EBIT (EV/EBIT) of 37.45. The EV to capital employed and EV to sales ratios are notably low at 0.85 and 0.63 respectively, which may indicate that the company’s enterprise value is relatively low compared to its capital base and sales, reinforcing the attractive valuation grade.
Comparative Peer Analysis
When compared with peers in the commodity chemicals sector, Kanoria Chemicals’ valuation stands out. For instance, Titan Biotech and Stallion India are classified as very expensive, with P/E ratios of 73.95 and 39.65 respectively, and EV/EBITDA multiples far exceeding Kanoria’s. Sanstar also falls into the very expensive category with a P/E of 85.45 and an EV/EBITDA of 86.77. Meanwhile, companies like Gulshan Polyols and TGV Sraac are rated very attractive, with P/E ratios of 27.54 and 9.05 respectively, and EV/EBITDA multiples significantly lower than Kanoria’s.
Kanoria’s PEG ratio of 2.48 is moderate but higher than some peers, indicating that the stock’s price growth relative to earnings growth is somewhat stretched. The company’s return on capital employed (ROCE) and return on equity (ROE) are low at 1.75% and 1.49% respectively, reflecting limited profitability and efficiency in capital utilisation at present.
Stock Performance Versus Sensex
Kanoria Chemicals has delivered mixed returns over various time horizons compared to the Sensex benchmark. Over the past week, the stock outperformed with a 6.00% gain versus the Sensex’s 0.17%. The one-month return is particularly strong at 46.98%, dwarfing the Sensex’s 5.04% gain. Year-to-date, Kanoria has risen 22.13%, while the Sensex has declined by 9.63%, highlighting the stock’s relative resilience in a challenging market environment.
However, longer-term performance paints a different picture. Over one year, Kanoria’s 7.95% gain still outpaces the Sensex’s negative 4.68%, but over three and five years, the stock has underperformed significantly, with returns of -20.54% and -24.09% respectively, compared to Sensex gains of 26.15% and 58.22%. Over a decade, Kanoria has delivered a respectable 51.46% return, though this pales in comparison to the Sensex’s 204.87% growth, underscoring the stock’s challenges in sustaining long-term outperformance.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Mojo Score and Rating Upgrade
Kanoria Chemicals & Industries Ltd currently holds a Mojo Score of 53.0, reflecting a moderate investment appeal. The Mojo Grade was recently upgraded from Sell to Hold on 4 May 2026, signalling a cautious but improved outlook by MarketsMOJO analysts. This upgrade aligns with the shift in valuation grade from very attractive to attractive, suggesting that while the stock remains a micro-cap with inherent risks, its price attractiveness has improved sufficiently to warrant a neutral stance rather than a sell recommendation.
Profitability and Dividend Considerations
Despite the valuation improvements, the company’s profitability metrics remain subdued. ROCE at 1.75% and ROE at 1.49% indicate limited returns on invested capital and shareholder equity. Dividend yield data is not available, which may reflect either a lack of dividend payments or inconsistent dividend policy. Investors should weigh these factors carefully, as low profitability can constrain future growth and shareholder returns.
Market Capitalisation and Liquidity
Kanoria Chemicals is classified as a micro-cap stock, which often entails higher volatility and lower liquidity compared to larger peers. This classification can impact institutional interest and price stability, factors that investors should consider alongside valuation and performance metrics.
Holding Kanoria Chemicals & Industries Ltd from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investment Outlook and Considerations
Kanoria Chemicals & Industries Ltd’s recent valuation upgrade reflects a more favourable price point relative to its book value and enterprise metrics, despite an exceptionally high P/E ratio. The stock’s recent outperformance against the Sensex on shorter time frames suggests some positive momentum, but the longer-term underperformance and low profitability metrics temper enthusiasm.
Investors should consider the company’s micro-cap status and the inherent risks of limited liquidity and volatility. The attractive P/BV ratio may appeal to value-oriented investors seeking exposure to the commodity chemicals sector, but the elevated P/E ratio and modest returns on capital caution against aggressive positioning.
Comparative analysis with peers reveals that while Kanoria is more attractively valued than several very expensive competitors, there are also peers rated very attractive with stronger profitability and lower valuation multiples. This underscores the importance of a thorough peer comparison and fundamental analysis before committing capital.
Overall, the upgrade to a Hold rating and the shift in valuation grade to attractive suggest that Kanoria Chemicals is at a potential inflection point. Investors with a higher risk tolerance and a long-term horizon may find the current valuation compelling, provided they monitor earnings developments and sector dynamics closely.
Summary
Kanoria Chemicals & Industries Ltd’s valuation parameters have improved, moving from very attractive to attractive, driven by a low price-to-book ratio and reasonable enterprise multiples despite a stretched P/E ratio. The stock’s recent relative strength versus the Sensex and the Mojo Grade upgrade to Hold reflect a cautiously optimistic outlook. However, subdued profitability and micro-cap risks remain key considerations. A balanced approach, incorporating peer comparisons and fundamental analysis, is advisable for investors evaluating this commodity chemicals player.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
